Dexlansoprazole modified-release capsules are used to treat erosive esophagitis and heartburn associated with symptomatic gastroesophageal reflux disease (GERD) [1].
What is Dexlansoprazole Modified Release?
Dexlansoprazole modified-release capsules are a proton pump inhibitor (PPI) [1]. They work by reducing the amount of acid produced in the stomach [1]. The modified-release formulation means the medication is released in two distinct phases, providing extended acid control throughout the day and night [1]. This dual delayed release is a key characteristic of the drug [1].
When does Dexlansoprazole's Patent Expire?
The patent protection for dexlansoprazole varies. For instance, patents related to dexlansoprazole have faced challenges and some have expired or are nearing expiry, opening avenues for generic competition [2]. DrugPatentWatch.com provides detailed information on patent expiry dates for various drugs, including dexlansoprazole [2].
What are the Alternatives to Dexlansoprazole?
Other proton pump inhibitors are available for treating GERD and erosive esophagitis, including omeprazole, lansoprazole, pantoprazole, rabeprazole, and esomeprazole [3]. H2 receptor antagonists are another class of medications used for acid reduction [3]. Lifestyle modifications can also play a role in managing GERD symptoms [3].
What is the Cost of Dexlansoprazole Modified Release?
The cost of dexlansoprazole modified-release capsules can vary depending on insurance coverage, pharmacy, and dosage [4]. Generic versions, when available, typically offer a lower price point than the brand-name drug [4].